The Association of British HealthTech Industries (ABHI) has signed a memorandum of understanding with the AHSN Network.
The partnership will see a joint commitment to developing and delivering services of mutual benefit, while ensuring health tech companies experience a consistent process, irrespective of the individual Academic Health Science Network (AHSN) they are working with.
The work will provide an important framework to strengthen the engagement between England’s 15 AHSNs and ABHI’s 280 member companies. To achieve this critical objective, both parties have agreed to collaborate on projects such as:
- Endorsement of the ABHI Code of Business Practice and credentialing arrangements
- Implementation of the Accelerated Access Collaborative
- Full and active collaboration on relevant Innovation National Networks.
ABHI Director, Healthcare Policy, Richard Phillips said: “The AHSNs represent one of the best vehicles for innovation at pace and scale in this country, and we have been supportive of their work from day one. We were delighted with their relicensing earlier this year. ABHI has partnered with the Network on a number of joint projects, and through this MOU, we look forward to developing this relationship further as we support their vital work.”
Professor Mike Hannay, Chair of the AHSN Network, said: “We have worked closely and constructively with the ABHI since AHSNs were first established back in 2013, and it is fantastic to see this relationship now being formalised.
“The AHSN Network sets out to make it easier for industry to do business with the NHS, particularly through our network of Innovation Exchanges and our role in spreading innovations via the Accelerated Access Collaborative. Our partnership with the ABHI will significantly enhance and strengthen the support we can offer to health tech companies, no matter where they are in the country, enabling us to realise the huge benefits this sector can bring to both the health and wealth of our populations.”
Earlier this year, the AHSN Network and The Association of the British Pharmaceutical Industry (ABPI) announced a five-year partnership to accelerate the introduction and uptake of transformative biomedical innovations into the NHS. Read more here.
News and blogs >
Collaborating for medicines safety Read more
A programme to reduce the avoidable harm caused by opioids is now on a firm footing in the North West Coast.
Launch of new lipid management pathway Read more
Clinicians in Cheshire and Merseyside have collaborated on a new lipid management pathway aimed at improving outcomes for people with cardiovascular disease (CVD).
Mental health innovators to benefit from £20m programme Read more
Health Innovation North West Coast is backing a programme to support innovators working at the forefront of mental health therapeutics
“Real world validation” being validated by the academic community Read more
A recent report demonstrates the acceptance of “real world” data from health care settings and the impact on patients being used to inform academic research.
